Clinical Trials Directory

Trials / Unknown

UnknownNCT02458794

Crossover Study of the LMA SupremeTM vs Ambu-Aura GainTM

A Randomized Crossover Study of the LMA SupremeTM Versus Ambu-Aura GainTM in Adult Patients

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
200 (estimated)
Sponsor
Schulthess Klinik · Academic / Other
Sex
All
Age
19 Years – 65 Years
Healthy volunteers
Not accepted

Summary

The Ambu-Aura GainTM is a new extraglottic airway device which brings together features of both the LMA ProSealTM (high seal cuff, gastric access and bite block - to facilitate ventilation, airway protection and airway obstruction, respectively) and the LMA UniqueTM (single use - prevention of disease transmission). In the following randomized, crossover study, the investigators test the hypothesis that ease of insertion, oropharyngeal leak pressure, fiberoptic position and ease of gastric tube placement differ between the Ambu-Aura GainTM and the LMA SupremeTM in paralyzed, anesthetized patients.

Conditions

Interventions

TypeNameDescription
PROCEDUREfunction testsease of insertion, oropharyngeal seal pressure, fiberoptic position, ease of ventilation, occult blood, gastric tube insertion
DEVICELMA SupremeTM
DEVICEAmbu-Aura GainTM

Timeline

Start date
2015-09-01
Primary completion
2016-03-01
Completion
2016-04-01
First posted
2015-06-01
Last updated
2015-07-29

Locations

2 sites across 2 countries: Italy, Switzerland

Source: ClinicalTrials.gov record NCT02458794. Inclusion in this directory is not an endorsement.